Back to search

Article

NMDA Receptor Potentiation and Severe Acute Respiratory Syndrome Treatment

2022-03-30

Abstract excerpt

An experimental compound (CNS004), reported to have various biological activities including antiviral, antimalarial, antiprotozoal and immunomodulatory effects, has been identified to potentiate NMDA subtype of glutamate receptors that are expressed in human lungs and central nervous system. We hypothesize that potentiating NMDA receptors will increase calcium ion influx and promote downstream signaling mechanisms...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e90a9861-07b1-513f-a218-f0bde22eef40
DOI
10.22541/au.164864550.08969022/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NMDA Receptor Potentiation and Severe Acute Respiratory Syndrome TreatmentDOI 10.22541/au.164864550.08969022/v1
Select a neighboring publication to make it the new centre.